Correspondence 0000856982-24-000081 from MERIT MEDICAL SYSTEMS INC (MMSI) (CIK 0000856982) (MMSI)
MERIT MEDICAL SYSTEMS INC (MMSI) (CIK 0000856982)
Date: Aug. 23, 2024 · CIK: 0000856982 · Accession: 0000856982-24-000081
AI Filing Summary & Sentiment
File numbers found in text: 000-18592
Referenced dates: August 9, 2024
Letter
August 23, 2024 Securities and Exchange Commission Division of Corporate Finance Disclosure Review Program 100 F Street, NE Washington, D.C. 20549 Attn: Charlotte Young and Amanda Ravitz Merit Medical Systems, Inc. Definitive Proxy Statement on Schedule 14A Filed April 2, 2024 File No. 000-18592
Re:
Dear Ms. Young and Ms. Ravitz:
Merit Medical Systems, Inc. (the “Company”), is in receipt of a letter dated August 9, 2024 (the “Comment Letter”) from the staff of the Securities and Exchange Commission (the “Staff”) concerning the above-captioned filing. To facilitate the Staff’s review, we have reproduced the text of the Staff’s comment in italics below, and our response appears immediately below the comment.
Comment:
1. Please provide a clear description of the relationship between compensation actually paid and net income, as required by Item 402(v)(5)(ii) of Regulation S-K. Please note that it is not sufficient to state that no relationship exists, even if a particular measure is not used in setting compensation.
Response: The Company undertakes to provide a clear description of the relationship between compensation actually paid and net income, as required by Regulation S-K Item 402(v)(5)(ii), in its future proxy statement disclosure.
The Staff is invited to contact the undersigned with any comments or questions it may have. We appreciate your assistance in addressing this matter.
Very truly yours,
Show Raw Text
CORRESP 1 filename1.htm August 23, 2024 Securities and Exchange Commission Division of Corporate Finance Disclosure Review Program 100 F Street, NE Washington, D.C. 20549 Attn: Charlotte Young and Amanda Ravitz Re: Merit Medical Systems, Inc. Definitive Proxy Statement on Schedule 14A Filed April 2, 2024 File No. 000-18592 Dear Ms. Young and Ms. Ravitz: Merit Medical Systems, Inc. (the “Company”), is in receipt of a letter dated August 9, 2024 (the “Comment Letter”) from the staff of the Securities and Exchange Commission (the “Staff”) concerning the above-captioned filing. To facilitate the Staff’s review, we have reproduced the text of the Staff’s comment in italics below, and our response appears immediately below the comment. Comment: 1. Please provide a clear description of the relationship between compensation actually paid and net income, as required by Item 402(v)(5)(ii) of Regulation S-K. Please note that it is not sufficient to state that no relationship exists, even if a particular measure is not used in setting compensation. Response: The Company undertakes to provide a clear description of the relationship between compensation actually paid and net income, as required by Regulation S-K Item 402(v)(5)(ii), in its future proxy statement disclosure. The Staff is invited to contact the undersigned with any comments or questions it may have. We appreciate your assistance in addressing this matter. Very truly yours, /s/ BRIAN G. LLOYD Brian G. Lloyd Chief Legal Officer Merit Medical Systems, Inc.